J. L. Bainbridge & Co., Inc. Merck & Co., Inc. Transaction History

J. L. Bainbridge & Co., Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $14,608 - $15,689	118 Added 7.29%	1,736 $214,000
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $183,222 - $213,495	1,618 New	1,618 $213,000
Q2 2022 Aug 04, 2022	SELL	$83.49 - $94.64 $1,586 - $1,798	-19 Reduced 0.32%	5,885 $537,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $10,124 - $11,198	144 Added 2.5%	5,904 $459,000
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $7,436 - $8,759	108 Added 1.91%	5,760 $444,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $24,881 - $28,203	340 Added 6.4%	5,652 $469,000
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $5,563 - $6,330	-79 Reduced 1.47%	5,312 $411,000
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $11,088 - $15,368	-175 Reduced 3.14%	5,391 $415,000
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $4,577 - $5,164	-59 Reduced 1.05%	5,566 $506,000
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $8,292 - $9,039	-109 Reduced 1.9%	5,625 $474,000
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $15,225 - $17,786	-218 Reduced 3.66%	5,734 $481,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $42,791 - $48,806	-615 Reduced 9.37%	5,952 $473,000
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $260 - $302	4 Added 0.06%	6,567 $502,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $378,619 - $445,233	6,563 New	6,563 $466,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.